Petrelintide reduced patients’ average body weight by up to 9.2%, compared to 2.0% among those who received placebo.

Roche partners with Hangzhou-based Defand Therapeutics in a ~$1B deal, under $10M upfront, to develop molecular glue ...

General Medicine raises a $120M Series B led by a16z, betting its 2,900-product catalog can serve AI shopping agents as well as people.

Chan Zuckerberg Biohub launches $1.8B Virtual Biology Initiative with Meta, Google DeepMind, Isomorphic Labs, DOE, and NIH to ...

Ultragenyx sells a rare pediatric disease PRV for $210M, one of 2026's priciest voucher deals, and plans to monetize a second ...

The World Health Organization on Wednesday recommended against GLP-1 drugs for children with obesity who are under 10 and ...

Nuvig cuts its CIDP trial, Cerevance's Parkinson's drug hits in Phase 3, plus RevMed, Tang's $75M SPAC, ViiV and AmyriAD news ...

PhRMA sued CMS over GLOBE, the Trump admin's Medicare Part B demo tying drug prices to overseas rates, calling it unlawful.

The court ruled that Merck infringed one of Halozyme's patents and granted an injunction that bars Merck from marketing subcutaneous Keytruda in Belgium, Denmark, France, Ireland, Italy, Sweden, ...

Bexorg wins $28.3M ARPA-H award to keep human donor brains alive up to 2 weeks for drug testing. Co-founded by Yale's Nenad Sestan and CEO Zvonimir Vrselja.

Caribou drops vispa-cel and CB-011, cuts staff and explores strategic alternatives after failing to fund its allogeneic CAR-T ...

The Palo Alto, CA-based firm announced a $600 million fund dedicated to Asia, where it is opening offices in Shanghai and Hong Kong.